The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Jul. 02, 2024

Filed:

May. 25, 2023
Applicant:

Aseko, Inc., Greenville, SC (US);

Inventors:

Robert C. Booth, Greer, SC (US);

Harry Hebblewhite, Atlanta, GA (US);

Assignee:

Aseko, Inc., Greenville, SC (US);

Attorneys:
Primary Examiner:
Int. Cl.
CPC ...
A61B 5/00 (2006.01); A61B 5/145 (2006.01); A61M 5/172 (2006.01); G16H 10/40 (2018.01); G16H 10/60 (2018.01); G16H 20/17 (2018.01); G16H 20/60 (2018.01); G16H 40/67 (2018.01); G16H 50/20 (2018.01); G16Z 99/00 (2019.01);
U.S. Cl.
CPC ...
A61B 5/0022 (2013.01); A61B 5/14503 (2013.01); A61B 5/14532 (2013.01); A61B 5/4839 (2013.01); A61M 5/1723 (2013.01); G16H 10/40 (2018.01); G16H 10/60 (2018.01); G16H 20/17 (2018.01); G16H 20/60 (2018.01); G16H 40/67 (2018.01); G16H 50/20 (2018.01); G16Z 99/00 (2019.02); A61M 2205/3303 (2013.01);
Abstract

A method of administering insulin includes receiving subcutaneous information for a patient at a computing device and executing a subcutaneous outpatient program for determining recommended insulin dosages. The subcutaneous outpatient program includes obtaining glucose data of the patient, aggregating glucose measurements to determine a representative aggregate glucose measurement associated with at least one scheduled glucose time interval, and determining a next recommended insulin dosage for the patient based on the representative aggregate glucose measurement and the subcutaneous information. The method also includes transmitting the next recommended insulin dosage to administration device associated with the patient.


Find Patent Forward Citations

Loading…